J Korean Diabetes.  2022 Dec;23(4):245-250. 10.4093/jkd.2022.23.4.245.

Diabetic Neuropathy and Risk of Cardiovascular Disease

• Yun JS

• KMID: 2538094
• DOI: http://doi.org/10.4093/jkd.2022.23.4.245

Abstract

Neuropathy is a common complication of diabetes that can appear in the early stages of diabetes or even in the prediabetes stage. The relationship between autonomic neuropathy and cardiovascular disease (CVD) is well established. Resting tachycardia, exercise intolerance, and non-dipping/reverse dipping caused by the relative overactivity of the sympathetic nervous system are the main factors that lead to the increased risk of CVD and cardiovascular mortality. Little is known, however, about the cardiovascular consequences of peripheral neuropathy (PN). Two recent major studies suggested the possibility of a significant association between PN and CVD and mortality; thus, cardiovascular risk management for patients with PN may be necessary. Positive results on MNSI (Michigan Neuropathy Screening Instrument) questionnaires and 10-g monofilament test are convenient methods for early screening and management of PN that may also be useful in evaluating PN-related CVD risk.

Keyword

Cardiovascular disease; Diabetic autonomic neuropathy; Diabetic neuropathy; Peripheral neuropathy

Reference

1.Pop-Busui R., Boulton AJ., Feldman EL., Bril V., Freeman R., Malik RA, et al. Diabetic neuropathy: a position statement by the American Diabetes Association. Diabetes Care. 2017. 40:136–54.

2.Bjerg L., Nicolaisen SK., Christensen DH., Nielsen JS., An-dersen ST., Jørgensen ME, et al. Diabetic polyneuropathy early in type 2 diabetes is associated with higher incidence rate of cardiovascular disease: results from two Danish cohort studies. Diabetes Care. 2021. 44:1714–21.

3.Hicks CW., Wang D., Matsushita K., Windham BG., Selvin E. Peripheral neuropathy and all-cause and cardiovascular mortality in U.S. adults: a prospective cohort study. Ann Intern Med. 2021. 174:167–74.

4.Pop-Busui R., Evans GW., Gerstein HC., Fonseca V., Fleg JL., Hoogwerf BJ, et al. Effects of cardiac autonomic dysfunction on mortality risk in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial. Diabetes Care. 2010. 33:1578–84.

5.Spallone V., Ziegler D., Freeman R., Bernardi L., Frontoni S., Pop-Busui R, et al. Cardiovascular autonomic neuropathy in diabetes: clinical impact, assessment, diagnosis, and management. Diabetes Metab Res Rev. 2011. 27:639–53.

6.Ang L., Dillon B., Mizokami-Stout K., Pop-Busui R. Cardiovascular autonomic neuropathy: a silent killer with long reach. Auton Neurosci. 2020. 225:102646.

7.Kuehl M., Stevens MJ. Cardiovascular autonomic neu-ropathies as complications of diabetes mellitus. Nat Rev Endocrinol. 2012. 8:405–16.

8.Yun JS., Ko SH., Ko SH., Song KH., Yoo KD., Yoon KH, et al. Cardiovascular disease predicts severe hypoglyce-mia in patients with type 2 diabetes. Diabetes Metab J. 2015. 39:498–506.

9.Yun JS., Ahn YB., Song KH., Yoo KD., Kim HW., Park YM, et al. The association between abnormal heart rate variability and new onset of chronic kidney disease in patients with type 2 diabetes: a ten-year follow-up study. Diabetes Res Clin Pract. 2015. 108:31–7.

10.Yun JS., Park YM., Cha SA., Ahn YB., Ko SH. Progression of cardiovascular autonomic neuropathy and Cardiovascular disease in type 2 diabetes. Cardiovasc Diabetol. 2018. 17:109.

11.Cha SA., Yun JS., Lim TS., Min K., Song KH., Yoo KD, et al. Diabetic cardiovascular autonomic neuropathy predicts recurrent cardiovascular diseases in patients with type 2 diabetes. PLoS One. 2016. 11:e0164807.

12.Spallone V. Blood pressure variability and autonomic dysfunction. Curr Diab Rep. 2018. 18:137.

13.Lonn EM., Rambihar S., Gao P., Custodis FF., Sliwa K., Teo KK, et al. Heart rate is associated with increased risk of major cardiovascular events, cardiovascular and all-cause death in patients with stable chronic cardiovascular disease: an analysis of ONTARGET/TRANSCEND. Clin Res Cardiol. 2014. 103:149–59.

14.Pop-Busui R. What do we know and we do not know about cardiovascular autonomic neuropathy in diabetes. J Cardiovasc Transl Res. 2012. 5:463–78.

15.Shivu GN., Abozguia K., Phan TT., Ahmed I., Weaver R., Narendran P, et al. Increased left ventricular torsion in un-complicated type 1 diabetic patients: the role of coronary microvascular function. Diabetes Care. 2009. 32:1710–2.

16.Huang CJ., Kuok CH., Kuo TB., Hsu YW., Tsai PS. Pre-op-erative measurement of heart rate variability predicts hypotension during general anesthesia. Acta Anaesthesiol Scand. 2006. 50:542–8.

17.Sassi R., Cerutti S., Lombardi F., Malik M., Huikuri HV., Peng CK, et al. Advances in heart rate variability signal analysis: joint position statement by the e-Cardiology ESC Working Group and the European Heart Rhythm Association co-endorsed by the Asia Pacific Heart Rhythm Society. Europace. 2015. 17:1341–53.

18.Pollard JD., Haq KT., Lutz KJ., Rogovoy NM., Paternos-tro KA., Soliman EZ, et al. Electrocardiogram machine learning for detection of cardiovascular disease in African Americans: the Jackson Heart Study. 2021. 2:137–51.

19.Hassan R., Huda S., Hassan MM., Abawajy J., Alsanad A., Fortino G. Early detection of cardiovascular autonomic neuropathy: a multi-class classification model based on feature selection and deep learning feature fusion. Inf Fusion. 2022. 77:70–80.

20.Ziegler D., Rathmann W., Dickhaus T., Meisinger C., Mielck A. Neuropathic pain in diabetes, prediabetes and normal glucose tolerance: the MONICA/KORA Augsburg Sur-veys S2 and S3. Pain Med. 2009. 10:393–400.

21.Seferovic JP., Pfeffer MA., Claggett B., Desai AS., de Zeeuw D., Haffner SM, et al. Three-question set from Michigan Neuropathy Screening Instrument adds independent prognostic information on cardiovascular outcomes: analysis of ALTITUDE trial. Diabetologia. 2018. 61:581–8.

22.American Diabetes Association. Peripheral arterial disease in people with diabetes. Diabetes Care. 2003. 26:3333–41.

23.Teunissen LL., Notermans NC., Wokke JH. Relationship between ischemia and neuropathy. Eur Neurol. 2000. 44:1–7.